Site Search

The UCLA Center for the Study of Parkinsons Disease, directed by Marie Françoise Chesselet,  uses an integrated multidisciplinary approach to elucidate the effects of nigrostraital lesions and treatment of Parkinsons disease on the molecular and cellular characteristics of the subthalamic nucleus. This region of the basal ganglia has recently emerged as an important focus for the development of novel therapeutic strategies for the disease. The goal of the Center is to identify new molecular targets of non-invasive pharmacological treatments of Parkinsons disease.

Interactions between the Center and clinical investigators in the Movement Disorders Program at UCLA provide an ideal conduit for the rapid translation of research findings into clinical applications. The Center provides a dynamic training environment that expands the research capabilities of scientists at all career levels and also their trainees.  The Center facilitates the participation of new investigators across the UCLA campus in research on Parkinson’s disease and reinforces the existing interactions between basic and clinical research on Parkinson’s disease at UCLA.

 


Upcoming EventsCOVER STORY
Samuel Eiduson - 1918-2007

 Carmine D. Clemente received Alpha Omega Alpha Robert J. Glaser Distinguished Teacher Award


BRI NewsIN THE NEWS

 Existing Drug Reverses a Form of Mental Retardation in Mice - 06/25/2008

 Visualizing Schizophrenia - 06/23/2008

 Common Sleep Problem Linked With Memory Loss - 06/22/2008

 Window on the Mind: Will the Antidepressant Work? - 05/05/2008

 Autism May Be More Genes Than Environment, Studies Say - 01/10/2008

 Scientists move toward helping paralysis patients - 01/06/2008

 BRI News Archive

 Newsroom.ucla.edu

Upcoming EventsUPCOMING EVENTS

 Joint Seminars in Neuroscience

 Neuroscience Seminars biweekly calendar